Moxibustion regulates T-regulatory/T-helper 17 cell balance by modulating the microRNA-221/suppressor of cytokine signaling 3 axis in a mouse model of rheumatoid arthritis.
10.1016/j.joim.2022.06.002
- Author:
Chuang ZHAO
1
,
2
;
Xiao-Yan LI
1
,
2
;
Zun-Yuan LI
1
,
2
;
Miao LI
1
,
2
;
Zhi-Dan LIU
1
,
3
Author Information
1. Department of Acupuncture, Baoshan Branch of Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 201999, China
2. Department of Acupuncture, Baoshan Hospital of Integrated Traditional Chinese Medicine and Western Medicine, Shanghai 201999, China.
3. Department of Acupuncture, Baoshan Hospital of Integrated Traditional Chinese Medicine and Western Medicine, Shanghai 201999, China. Electronic address: liuzhidan@vip.163.com.
- Publication Type:Journal Article
- Keywords:
MicroRNA-221;
Moxibustion;
Rheumatoid arthritis;
Suppressor of cytokine signaling 3;
T-regulatory/T-helper 17 cell balance
- MeSH:
Animals;
Arthritis, Experimental/therapy*;
Arthritis, Rheumatoid/therapy*;
Cytokines;
Disease Models, Animal;
Interleukin-10;
Interleukin-17;
Interleukin-6;
Male;
Mice;
Mice, Inbred DBA;
MicroRNAs/genetics*;
Moxibustion;
T-Lymphocytes, Regulatory;
Th17 Cells/pathology*;
Tumor Necrosis Factor-alpha
- From:
Journal of Integrative Medicine
2022;20(5):453-462
- CountryChina
- Language:English
-
Abstract:
OBJECTIVE:Rheumatoid arthritis (RA) progression is associated with the balance of T-regulatory (Treg) and T-helper 17 (Th17) cells, while the role of microRNAs (miRs) in regulating Treg/Th17 cell balance has not been clarified. This study aimed to assess whether moxibustion could regulate Treg/Th17 cell balance by modulating the miR-221/suppressor of cytokine signaling 3 (SOCS3) axis in the RA mouse model.
METHODS:A mouse model of collagen-induced arthritis (CIA) was established in male DBA/1J mice. Twenty-two days after CIA induction, the mice received daily treatment with moxibustion for 12 times. Pathological scores were assessed according to the levels of synovial hyperplasia. The expression levels of cytokines interleukin (IL)-1β, IL-6, tumor necrosis factor-α (TNF-α), interferon-γ (IFN-γ), IL-17 and IL-10 were analyzed in serum by enzyme-linked immunosorbent assay. The cluster of differentiation 4 (CD4+) splenocytes was analyzed by fluorescence-activated cell sorting. The expression levels of RA-related miRs and target genes were subsequently detected, and the target of miR-221 was confirmed by the dual-luciferase reporter assay.
RESULTS:It was revealed that moxibustion treatment decreased the pathological scores and downregulated the expression levels of IL-1β, IL-6, TNF-α, IFN-γ and IL-17, while upregulated the expression level of IL-10. The Treg/Th17 cell balance was regulated by moxibustion treatment. The expression level of miR-221 was suppressed by moxibustion treatment. Furthermore, SOCS3 was found as the direct target of miR-221, which mediated the function of moxibustion by regulating the Treg/Th17 cell balance.
CONCLUSION:Moxibustion therapy regulated the Treg/Th17 cell balance by modulating the miR-221/SOCS3 axis in the RA mouse model.
